Nature de la demande
Réévaluation du SMR
Service Médical Rendu (SMR)
| Faible |
Le service médical rendu par MEGACE 160 mg est faible dans le traitement palliatif des carcinomes du sein.
|
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
mCKaVk9hFHHX0DzS
